PFKFB3: A Potential Key to Ocular Angiogenesis

The current treatment for ocular pathological angiogenesis mainly focuses on anti-VEGF signals. This treatment has been confirmed as effective despite the unfavorable side effects and unsatisfactory efficiency. Recently, endothelial cell metabolism, especially glycolysis, has been attracting attenti...

Full description

Bibliographic Details
Main Authors: Zi-Yi Zhou, Lin Wang, Yu-Sheng Wang, Guo-Rui Dou
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2021.628317/full
id doaj-63ee33999faa4f968b0cac7f04499662
record_format Article
spelling doaj-63ee33999faa4f968b0cac7f044996622021-03-11T05:18:08ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2021-03-01910.3389/fcell.2021.628317628317PFKFB3: A Potential Key to Ocular AngiogenesisZi-Yi Zhou0Lin Wang1Yu-Sheng Wang2Guo-Rui Dou3Department of Ophthalmology, Xijing Hospital, Eye Institute of Chinese PLA, Fourth Military Medical University, Xi’an, ChinaDepartment of Hepatobiliary Surgery, Xijing Hospital, Fourth Military Medical University, Xi’an, ChinaDepartment of Ophthalmology, Xijing Hospital, Eye Institute of Chinese PLA, Fourth Military Medical University, Xi’an, ChinaDepartment of Ophthalmology, Xijing Hospital, Eye Institute of Chinese PLA, Fourth Military Medical University, Xi’an, ChinaThe current treatment for ocular pathological angiogenesis mainly focuses on anti-VEGF signals. This treatment has been confirmed as effective despite the unfavorable side effects and unsatisfactory efficiency. Recently, endothelial cell metabolism, especially glycolysis, has been attracting attention as a potential treatment by an increasing number of researchers. Emerging evidence has shown that regulation of endothelial glycolysis can influence vessel sprouting. This new evidence has raised the potential for novel treatment targets that have been overlooked for a long time. In this review, we discuss the process of endothelial glycolysis as a promising target and consider regulation of the enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase as treatment for ocular pathological angiogenesis.https://www.frontiersin.org/articles/10.3389/fcell.2021.628317/fullocular angiogenesisPFKFB3endothelial metabolismglycolysisendothelial cell
collection DOAJ
language English
format Article
sources DOAJ
author Zi-Yi Zhou
Lin Wang
Yu-Sheng Wang
Guo-Rui Dou
spellingShingle Zi-Yi Zhou
Lin Wang
Yu-Sheng Wang
Guo-Rui Dou
PFKFB3: A Potential Key to Ocular Angiogenesis
Frontiers in Cell and Developmental Biology
ocular angiogenesis
PFKFB3
endothelial metabolism
glycolysis
endothelial cell
author_facet Zi-Yi Zhou
Lin Wang
Yu-Sheng Wang
Guo-Rui Dou
author_sort Zi-Yi Zhou
title PFKFB3: A Potential Key to Ocular Angiogenesis
title_short PFKFB3: A Potential Key to Ocular Angiogenesis
title_full PFKFB3: A Potential Key to Ocular Angiogenesis
title_fullStr PFKFB3: A Potential Key to Ocular Angiogenesis
title_full_unstemmed PFKFB3: A Potential Key to Ocular Angiogenesis
title_sort pfkfb3: a potential key to ocular angiogenesis
publisher Frontiers Media S.A.
series Frontiers in Cell and Developmental Biology
issn 2296-634X
publishDate 2021-03-01
description The current treatment for ocular pathological angiogenesis mainly focuses on anti-VEGF signals. This treatment has been confirmed as effective despite the unfavorable side effects and unsatisfactory efficiency. Recently, endothelial cell metabolism, especially glycolysis, has been attracting attention as a potential treatment by an increasing number of researchers. Emerging evidence has shown that regulation of endothelial glycolysis can influence vessel sprouting. This new evidence has raised the potential for novel treatment targets that have been overlooked for a long time. In this review, we discuss the process of endothelial glycolysis as a promising target and consider regulation of the enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase as treatment for ocular pathological angiogenesis.
topic ocular angiogenesis
PFKFB3
endothelial metabolism
glycolysis
endothelial cell
url https://www.frontiersin.org/articles/10.3389/fcell.2021.628317/full
work_keys_str_mv AT ziyizhou pfkfb3apotentialkeytoocularangiogenesis
AT linwang pfkfb3apotentialkeytoocularangiogenesis
AT yushengwang pfkfb3apotentialkeytoocularangiogenesis
AT guoruidou pfkfb3apotentialkeytoocularangiogenesis
_version_ 1724225919210487808